RE:RE:RE:RE:RE:In case any NL employees follow this thread... All good points. It's just that IR has told investors differently. I was told that they weren't waiting until Health Canada approved their enclosure before releasing contract news. Also, they told me that they planned to release one contract and to see how the market receives it - and then to decide when to release the second contract.
I myself, have tried to make excuses and put myself in their shoes to try to think of what creative strategic plan they may have - but why tell us one thing and do another? They are just making deadlines for themselves that make them look bad when they don't achieve it. It's important to remember that these contracts were promised back in Jan.
It is better to be honest about setbacks because you risk looking incapable. I am hoping that after the trading day ends we get news and this is all mute. I will be the first to post congratulations.
I represent a few investors and we chose this company because we believed in the business plan (both short term and long term). We thought that they have a well designed exit plan (which involves a poison pill, and a low cost way of creating inherent value with the intellectual property). The long term value is with the IP, and the short term value is with extraction (Valens and Labs were used as examples of peers). As of today - the value of the IP has proved to have some limited value with the initial contract; but the extraction is non existent.
I also question whether they thought that they would be bought over by now and are scrambling to try to become functional (which they weren't really thinking they would have to do).
If it's true that they are saving money on news releases, I question the decision to releasng NRs for every patent along the way. The investor market clearly isn't valuing them at this time.
Perhaps they always intended to just be a scientific research company that sold big one day. But to sell big from this current position we need to increase the stock price to get into position - which means that financial value (rising profit) needs to be seen first. Thus, investors have to be confident in the company's ability to get contracts.
A number of times I have talked to IR and they told me that my specific financial questions would be answered by their CFO and that he would call me back that day. This was weeks ago. They offered for him to call me back twice like this - it wasn't my idea. I would totally accept them saying that he was too busy - totally understandable. It's just why propose that he call me numerous times? I know it's a little thing, but all of it together is starting to be red flags for us.
I hope to be proven wrong after the final bell.
Sorry to rant, but for the first time disappointment is really starting to set in. I don't think it is unjustified.